日本电子医疗记录市场 - 2025-2033

2024 年日本电子病历市场规模达 4.9483 亿美元，预计到 2033 年将达到 8.5355 亿美元，在 2025-2033 年预测期内的复合年增长率为 6.3%。

电子病历 (EMR) 是指医疗保健提供者办公室中的纸本图表的数位版本。电子病历 (EMR) 是以电子方式储存的病患资讯的集合，通常由医疗保健提供者用于诊断、治疗和病患照护管理。电子病历 (EMR) 包含患者临床就诊期间收集的资料，包括病史、诊断、药物、治疗计划、检查结果和其他相关健康资讯。

本质上，EMR 是现代医疗保健 IT 系统的关键组成部分，旨在提高医疗保健服务的品质、可近性和效率。它们透过促进即时存取患者资料、加强医疗团队之间的协作以及支持临床决策，在医疗保健的数位转型中发挥重要作用。

市场动态：

驾驶员和约束装置

技术进步和数位转型正在显着推动日本电子病历市场的成长

云端运算透过提供经济高效、可扩展且安全的资料储存解决方案彻底改变了医疗保健产业。传统上需要大型内部基础设施的 EMR 系统现在可以託管在云端，从而降低了医疗保健提供者（尤其是小型医院和诊所）的成本。因此，日本的市场参与者正在将 EMR 推进到基于云端的系统，这将在预测期内推动市场发展。

例如，2023 年 4 月，PHC Holdings Corporation 的全资子公司 Wemex Corporation 为日本的诊所推出了整合式电子病历 (EMR) 系统 Medicom-HRf 混合云端。新发布的Medicom-HRf混合云端是一种高端EMR模型，可以快速且灵活地响应医疗保健领域的数位转型，例如线上保险资格验证和电子处方。该产品保留了前代产品的高操作性和用户友好的输入速度，并且加入了云端技术，可以在多个地点使用，无需专用设备。

人工智慧驱动的 EMR 系统透过提供大量医疗保健资料的见解来增强决策能力。这些系统可以分析患者资料以提供临床决策支援、建议治疗计划，甚至预测患者结果。日本医疗保健系统面临的重大挑战之一是各个医院、诊所和药局之间的资料分散化。最近的技术进步促进了可互通的 EMR 系统的发展，使得不同的医疗保健提供者之间能够无缝共享患者资讯。

资料隐私和安全问题阻碍市场成长

儘管数位健康解决方案的采用率日益提高，但这些问题仍然是医疗保健提供者、患者和技术开发人员面临的主要障碍。医疗资料的敏感度加上严格的法规，为日本广泛采用电子病历 (EMR) 带来了障碍。日本拥有一些最严格的资料保护法，要求 EMR 系统遵守《个人资讯保护法》（PIPA）。这些法规确保了个人资料的安全，但也使医疗保健提供者采用 EMR 的过程变得更加复杂。

全球医疗保健领域网路攻击和资料外洩事件的增加也加剧了日本的担忧。由于医疗资料的敏感性，医疗保健系统经常成为网路犯罪分子的目标，而医疗数据在黑市上价值极高。日本的医疗资料安全系统面临危及患者资料的攻击，导致医疗保健提供者对全面采用 EMR 犹豫不决。对于 EMR 的接受度来说，需要能够保护敏感医疗资讯的网路安全解决方案。

目录

第一章：市场介绍和范围

• 报告目标
• 报告范围和定义
• 报告范围

第二章：高阶主管见解与关键要点

• 市场亮点和战略要点
• 主要趋势和未来预测
• 按类型分类的程式码片段
• 按部署模式的程式码片段
• 按应用程式截取的程式码片段
• 最终用户的程式码片段

第三章：动态

• 影响因素
  • 驱动程式
    • 技术进步与数位转型
    • 人口老化和医疗保健需求成长
  • 限制
    • 资料隐私和安全问题
    • 初始投资和维护成本高
  • 机会
    • EMR软体的进步
  • 影响分析

第四章：战略洞察与产业展望

• 市场领导者和先驱者
  • 新兴先锋和杰出参与者
  • 拥有最大行销品牌的既定领导者
  • 拥有成熟产品的市场领导者
• 最新进展与突破
• 日本监管与报销格局
• 供应链分析
• 波特五力分析
• SWOT分析
• 未满足的需求和差距
• 市场进入和扩张的推荐策略
• 情境分析：最佳情况、基本情况和最坏情况预测
• 定价分析和价格动态

第五章：电子医疗记录市场（按类型）

• 传统电子病历
• 支援语音的电子病历
• 可互通的电子病历
• 其他的

第六章：电子医疗记录市场（依部署模式）

• 基于云端
• 本地部署
• 杂交种

第七章：电子医疗记录市场（按应用）

• 临床电子病历
• 行政电子病历
• 报告电子病历
• 其他的

第 8 章：电子医疗记录市场（按最终用户划分）

• 医院
• 专科诊所
• 门诊护理中心
• 诊断中心
• 其他的

第九章：竞争格局与市场定位

• 竞争概况和主要市场参与者
• 市占率分析与定位矩阵
• 策略伙伴关係、併购
• 产品组合和创新的关键发展
• 公司基准化分析

第十章：公司简介

• Fujitsu Limited
• 公司概况
• 产品组合
  • 产品描述
  • 产品关键绩效指标 (KPI)
  • 历史和预测产品销售
  • 产品销售量
• 财务概览
  • 公司收入
  • 地区收入份额
  • 收入预测
• 关键进展
  • 併购
  • 关键产品开发活动
  • 监管部门批准等
• SWOT分析
• NEC Corporation
• OmniMD
• CANON MEDICAL SYSTEMS CORPORATION
• PHC Holdings Corporation
• Nihon Kohden Corporation
• Juvonno
• ESO Solutions, Inc.

第 11 章：假设与研究方法

• 资料收集方法
• 数据三角测量
• 预测技术
• 数据验证和确认

第 12 章：附录

The Japan electronic medical records market size reached US$ 494.83 million in 2024 and is expected to reach US$ 853.55 million by 2033, growing at a CAGR of 6.3% during the forecast period 2025-2033.

Electronic Medical Records (EMRs) refer to a digital version of the paper charts in a healthcare provider's office. An Electronic Medical Record (EMR) is a collection of patient information stored electronically, typically used by healthcare providers for diagnosis, treatment, and patient care management. Electronic medical records (EMRs) contain data gathered during a patient's clinical visits, including medical history, diagnoses, medications, treatment plans, test results, and other relevant health information.

In essence, EMRs are a key component of modern healthcare IT systems, aimed at improving the quality, accessibility, and efficiency of healthcare services. They play an essential role in the digital transformation of healthcare by facilitating real-time access to patient data, enhancing collaboration among healthcare teams, and supporting clinical decision-making.

Market Dynamics: Drivers & Restraints

Technological advancements and digital transformation are significantly driving the Japan electronic medical records market growth

Cloud computing has revolutionized the healthcare industry by providing cost-effective, scalable, and secure data storage solutions. EMR systems, which traditionally required large on-premise infrastructure, can now be hosted in the cloud, reducing costs for healthcare providers, especially smaller hospitals and clinics. Thus, the market players in Japan are advancing the EMRs into cloud-based systems, which is driving the market over the forecast period.

For instance, in April 2023, Wemex Corporation, a wholly owned subsidiary of PHC Holdings Corporation, launched an integrated electronic medical record (EMR) system, Medicom-HRf Hybrid Cloud, for clinics in Japan. The newly released Medicom-HRf Hybrid Cloud is a high-end EMR model that can quickly and flexibly respond to the digital transformation in healthcare, such as online insurance eligibility verification and e-prescriptions. The product retains the high operability and user-friendly input speed of the previous models, and the addition of cloud technology means it can be used from many locations without dedicated devices.

AI-powered EMR systems enhance decision-making by providing insights from vast amounts of healthcare data. These systems can analyze patient data to offer clinical decision support, suggest treatment plans, and even predict patient outcomes. One of the significant challenges in Japan's healthcare system has been data fragmentation across various hospitals, clinics, and pharmacies. Recent technological advancements have led to the development of interoperable EMR systems that allow the seamless sharing of patient information across different healthcare providers.

Data privacy and security concerns hampering market growth

Despite the increasing adoption of digital health solutions, these concerns remain a major barrier for healthcare providers, patients, and technology developers. The sensitive nature of medical data, coupled with stringent regulations, creates obstacles to the widespread adoption of EMRs in Japan. Japan has some of the strictest data protection laws, which require EMR systems to comply with the Personal Information Protection Act (PIPA). These regulations ensure the security of personal data but also make the process of adopting EMRs more complex for healthcare providers.

The rise in cyberattacks and data breaches in healthcare globally has heightened concerns in Japan as well. Healthcare systems are often targeted by cybercriminals due to the sensitive nature of medical data, which is highly valuable in the black market. Japan's healthcare data security systems have faced attacks that compromise patient data, causing healthcare providers to hesitate in fully adopting EMRs. The need for cybersecurity solutions that can protect sensitive medical information is vital for the acceptance of EMRs.

Segment Analysis

The Japan electronic medical records market is segmented based on type, deployment mode, application, and end-user.

Deployment Mode:

The cloud-based EMRs segment is expected to dominate the Japan electronic medical records market with the highest market share

Cloud-based EMR systems offer significant cost advantages compared to traditional on-premise systems. Healthcare providers, especially smaller hospitals and clinics, face lower upfront costs because they don't need to invest in expensive hardware infrastructure or worry about its maintenance and upgrades. Instead, cloud-based systems operate on a subscription model, allowing healthcare providers to scale up or down based on their needs. Thus, novel cloud-based launches are further driving the segment growth.

For instance, in April 2023, Fujitsu launched a cloud-based platform that allows users to securely collect and leverage health-related data to promote digital transformation in the medical field. The new platform enables the automatic conversion of medical data from medical institutions' electronic medical records to conform to the next-generation standards framework, HL7 FHIR, and secure aggregation of health-related data. Based on their consent, patients can securely store personal health information such as vital data, step counts, and calorie consumption converted into non-personally identifiable information on the platform.

Cloud-based EMRs in Japan are designed with advanced security protocols, ensuring that sensitive health data is protected in line with Japan's stringent data protection laws, such as the Personal Information Protection Act (PIPA). Major cloud service providers also offer data encryption, multi-factor authentication, and regular system updates, ensuring high security and compliance with national and international standards.

Competitive Landscape

Top companies in the Japan electronic medical records market include Fujitsu Limited, NEC Corporation, OmniMD, CANON MEDICAL SYSTEMS CORPORATION, PHC Holdings Corporation, Nihon Kohden Corporation, Juvonno, ESO Solutions, Inc., and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan electronic medical records market report delivers a detailed analysis with 36 key tables, more than 33 visually impactful figures, and 198 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Type
• 2.4. Snippet by Deployment Mode
• 2.5. Snippet by Application
• 2.6. Snippet by End-User

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Technological Advancements and Digital Transformation
    • 3.1.1.2. Aging Population and Increasing Healthcare Demand
  • 3.1.2. Restraints
    • 3.1.2.1. Data Privacy and Security Concerns
    • 3.1.2.2. High Initial Investment and Maintenance Costs
  • 3.1.3. Opportunity
    • 3.1.3.1. Advancements in EMR software
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established Leaders with Largest Marketing Brand
  • 4.1.3. Market Leaders with Established Products
• 4.2. Latest Developments and Breakthroughs
• 4.3. Japan Regulatory and Reimbursement Landscape
• 4.4. Supply Chain Analysis
• 4.5. Porter's Five Forces Analysis
• 4.6. SWOT Analysis
• 4.7. Unmet Needs and Gaps
• 4.8. Recommended Strategies for Market Entry and Expansion
• 4.9. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.10. Pricing Analysis and Price Dynamics

5. Electronic Medical Records Market, By Type

• 5.1. Introduction
  • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 5.1.2. Market Attractiveness Index, By Type
• 5.2. Traditional EMRs*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 5.3. Speech-enabled EMRs
• 5.4. Interoperable EMRs
• 5.5. Others

6. Electronic Medical Records Market, By Deployment Mode

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
  • 6.1.2. Market Attractiveness Index, By Deployment Mode
• 6.2. Cloud-Based*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. On-Premise
• 6.4. Hybrid

7. Electronic Medical Records Market, By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Clinical EMR*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Administrative EMR
• 7.4. Reporting EMR
• 7.5. Others

8. Electronic Medical Records Market, By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Specialty Clinics
• 8.4. Ambulatory Care Centers
• 8.5. Diagnostic Centers
• 8.6. Others

9. Competitive Landscape and Market Positioning

• 9.1. Competitive Overview and Key Market Players
• 9.2. Market Share Analysis and Positioning Matrix
• 9.3. Strategic Partnerships, Mergers & Acquisitions
• 9.4. Key Developments in Product Portfolios and Innovations
• 9.5. Company Benchmarking

10. Company Profiles

• 10.1. Fujitsu Limited*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio
    • 10.1.2.1. Product Description
    • 10.1.2.2. Product Key Performance Indicators (KPIs)
    • 10.1.2.3. Historic and Forecasted Product Sales
    • 10.1.2.4. Product Sales Volume
  • 10.1.3. Financial Overview
    • 10.1.3.1. Company Revenue
    • 10.1.3.2. Geographical Revenue Shares
    • 10.1.3.3. Revenue Forecasts
  • 10.1.4. Key Developments
    • 10.1.4.1. Mergers & Acquisitions
    • 10.1.4.2. Key Product Development Activities
    • 10.1.4.3. Regulatory Approvals, etc.
  • 10.1.5. SWOT Analysis
• 10.2. NEC Corporation
• 10.3. OmniMD
• 10.4. CANON MEDICAL SYSTEMS CORPORATION
• 10.5. PHC Holdings Corporation
• 10.6. Nihon Kohden Corporation
• 10.7. Juvonno
• 10.8. ESO Solutions, Inc.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

• 11.1. Data Collection Methods
• 11.2. Data Triangulation
• 11.3. Forecasting Techniques
• 11.4. Data Verification and Validation

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us